-
Mashup Score: 1#TogetherSeparately en Español - Lung Cancer Research Foundation - 3 hour(s) ago
Read English translation 7 de noviembre de 4:00 a 5:00 de la tarde EST La Dra. Coral Olazagasti y la Dra. nos acompañarán para una charla comunitaria sobre el cáncer de pulmón el día jueves, 7 de noviembre, de 4 a 5 de la tarde ET. Con la Dra. Ana Velázquez Mañana como moderadora, brindarán un […]
Categories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 20
Read English translation 7 de noviembre de 4:00 a 5:00 de la tarde EST La Dra. Coral Olazagasti y la Dra. nos acompañarán para una charla comunitaria sobre el cáncer de pulmón el día jueves, 7 de noviembre, de 4 a 5 de la tarde ET. Con la Dra. Ana Velázquez Mañana como moderadora, brindarán un […]
Categories: General Medicine News, Hem/OncsTweet-
🚨Don’t miss this @lcrf_org webinar in Spanish about lung cancer for patients & caregivers No te pierdas esta charla communitaria sobre Cancer del Pulmón - virtual 📆 Nov 7th, 4PM ET 👉🏽Register at: https://t.co/Tv5Wl85Clh @AnaVManana @COlazagasti @SylvesterCancer #LCAM #lcsm… https://t.co/CakXEope5J https://t.co/zV0euXyiIW
-
-
Mashup Score: 0
Fat Joe is calling out his fellow Puerto Ricans who continue to support Donald Trump in the presidential election, saying they are ‘acting white.’
Source: hiphopdx.comCategories: General Medicine News, Hem/OncsTweet-
🍿Following the drama of boricua🇵🇷 rappers and who they are endorsing for this election, but my always favorite is @fatjoe who brings up the Puertorican identity issue in this interview and how that influences 🗳️ voting. -- https://t.co/6m5LzIdlVV via @hiphopdx
-
-
Mashup Score: 21Researchers Selected for ASCO Scholars Program - 14 day(s) ago
Three of the 18 new mentors are from Sylvester, and they will contribute to the development of cancer research in Brazil. By Zeth Leon The American Society of Clinical Oncologists (ASCO) recently announced that 18 mentors were selected to assist in fostering a new generation of cancer researchers in
Source: www.linkedin.comCategories: General Medicine News, Hem/OncsTweet-
@SylvesterCancer Researchers Selected for @ASCO Scholars Program to train next generation of scientists in #LATAM"https://t.co/CiJOwydMKX on
-
-
Mashup Score: 5
/PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced positive top-line results from the Phase 3 clinical trial evaluating Zepzelca®…
Source: www.prnewswire.comCategories: General Medicine News, Hem/OncsTweet-
Catching up on the 🫁 press release data- Jazz Announces Statistically Significant OS advantage to lurbinectedin+ atezolizumab maintenance in ES-SCLC. Great to see -but need to see details of magnitude of survival, AE, and comparison arm tx. #lcsm https://t.co/do5MliVrUT
-
-
Mashup Score: 3TikTok · Coral Olazagasti MD - 1 month(s) ago
53 likes, 4 comments. “Happy Hispanic Physician Day to us!”
Source: www.tiktok.comCategories: General Medicine News, Hem/OncsTweet-
RT @COlazagasti: It’s National Hispanic Physician Day! @SylvesterCancer @Florez_Lab #TikTok https://t.co/pXBvzG7MrE
-
-
Mashup Score: 1NSCLC EGFR+ en Etapa Temprana - 2024 Foro de Terapias Dirigidas 2024 - 1 month(s) ago
El Foro de Terapias Dirigidas de Cáncer de Pulmón en Español fue un evento en directo celebrado en julio de 2024 que reunió a los mejores oncólogos para deba…
Source: www.youtube.comCategories: General Medicine News, Hem/OncsTweet-
RT @cancerGRACE: NSCLC EGFR+ en Etapa Temprana - 2024 Foro de Terapias Dirigidas 2024 https://t.co/1oMZOOavOC via @YouTube En este video,…
-
-
Mashup Score: 663 Hispanic and Latino leaders to know | 2024 - 1 month(s) ago
Becker’s is thrilled to honor Hispanic and Latino healthcare leaders. Diverse leadership in healthcare culminates in a more comprehensive, seamless experience.
Source: www.beckershospitalreview.comCategories: General Medicine News, Hem/OncsTweet-
Humbled to be recognized among so many impressive Hispanic Latino leaders to know in healthcare including @DrFrankJPenedo @SylvesterCancer #HispanicHeritageMonth https://t.co/kmev6Sr1tx
-
-
Mashup Score: 1First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial - 2 month(s) ago
Nivolumab plus ipilimumab provided significant and clinically meaningful improvements in overall survival versus standard-of-care chemotherapy, supporting the use of this first-in-class regimen that has been approved in the USA as of October, 2020, for previously untreated unresectable MPM.
Source: www.thelancet.comCategories: General Medicine News, Hem/OncsTweet-
https://t.co/bLlnDZVpqX
-
-
Mashup Score: 0
In patients with advanced pleural mesothelioma, the addition of pembrolizumab to standard platinum–pemetrexed chemotherapy was tolerable and resulted in a significant improvement in overall survival. This regimen is a new treatment option for previously untreated advanced pleural mesothelioma.
Source: www.thelancet.comCategories: General Medicine News, Hem/OncsTweet-
https://t.co/jC8Bx5inzZ
-
🚨Don’t miss this @lcrf_org webinar in Spanish about lung cancer for patients & caregivers No te pierdas esta charla communitaria sobre Cancer del Pulmón - virtual 📆 Nov 7th, 4PM ET 👉🏽Register at: https://t.co/Tv5Wl85Clh @AnaVManana @COlazagasti @SylvesterCancer #LCAM #lcsm… https://t.co/CakXEope5J https://t.co/zV0euXyiIW